OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Allergy and Clinical Immunology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
What molecular allergy teaches us about genetics and epidemiology of allergies	52
The use of environmental exposure chambers in studies related to ocular surface effects	34
Consequences of severe asthma exacerbations	31
The pathogenetic role of Th17 immune response in atopic dermatitis	31
Economic burden of drug-induced anaphylaxis: what can we do better?	26
Is immunotherapy safe for treatment of severe asthma	25
Chronic spontaneous urticaria: new evidences on the role of autoimmunity	22
Liver disease in primary antibody deficiencies	22
Anaphylaxis due to antiallergic and antiasthmatic biologics	21
E-cigarettes and asthma in adolescents	18
Drug allergy awareness and perspectives with the implementation of the International Classification of Diseases-11	17
The collaborative medical practice of the ocular surface: a major role of the allergist/immunologist	16
Dietary strategies for the prevention of asthma in children	16
Real-world evidence of allergen immunotherapy	15
Cow's milk allergy	15
Pulmonary function testing for the diagnosis of asthma in preschool children	15
Editorial: Food allergy: from defense to attack	14
New approaches in childhood asthma treatment	14
Atopic manifestations of inborn errors of immunity	14
Innate and adaptive immunity in allergic airway disease	13
Vernal keratoconjunctivitis and keratoconus	12
Biologics as treatment options for anaphylaxis	12
Bronchiectasis and obstructive lung diseases in primary antibody deficiencies and beyond: update on management and pathomechanisms	12
Update on occupational allergy, including asthma, to soluble platinum salts	12
Autologous serum eye drops for ocular surface disorders	12

The effects of the COVID-19 pandemic on the treatment of allergic eye diseases	12
Mast cell conditions and drug allergy: when to suspect and how to manage	12
Transition of care in inborn errors of immunity	12
Editorial introductions	12
Neuroimmune signalling pathways in chronic rhinosinusitis with nasal polyps	12
Ocular involvement in allergic drug reactions	11
Editorial introductions	11
Paucity of gastrointestinal plasma cells in common variable immunodeficiency	11
Epidemiology of the relationship between allergic bronchopulmonary aspergillosis and asthma	10
Biological therapies, asthma and coronavirus disease 2019	10
Perioperative anaphylaxis: when the allergological work-up goes negative	10
Is allergen immunotherapy a model of personalized treatment in pediatric respiratory allergy?	10
Editorial introductions	10
Drug allergy desensitization is not a unique recipe	10
Nanoparticles in allergen immunotherapy	10
Updates in diagnosis and management of paediatric mastocytosis	9
A review of food allergy-related costs with consideration to clinical and demographic factors	9
Updates in school-based asthma management	9
LNIT-Local nasal immunotherapy in allergic rhinitis: revisited evidence and perspectives	9
Evaluating the glucagon-like peptide-1 receptor in managing asthma	9
Clinical remission in severe asthma: lights and shadows on an ambitious goal	9
Editorial introductions	9
Editorial introductions	9
Management and treatment of perioperative hypersensitivity	9
An immunologist's perspective on anti-COVID-19 vaccines	9
Editorial: Advances in drug hypersensitivity reactions	8
Chronic rhinosinusitis with nasal polyps: eosinophils versus B lymphocytes in disease pathogenesis	8
Occupational causes of chronic obstructive pulmonary disease: an update	8
Health disparities in allergic diseases	8
Greater mechanistic understanding of the cutaneous pathogenesis of Stevens–Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review	8
Basophil activation test in food allergy: is it ready for real-time?	8
Food-labeling issues for severe food-allergic consumers	8
Biomarkers in the diagnosis of mast cell activation	7
Role of the ocular surface microbiome in allergic eye diseases	7
What's new in pediatric asthma and rhinitis phenotypes and endotypes?	7
Editorial introductions	7
Food allergy: new therapeutic options open deeper questions	7
Strengthening the case for intralymphatic immunotherapy	7
Update on hereditary C1q deficiency: pathophysiology, clinical presentation, genotype and management	7
Atopic dermatitis endotypes: knowledge for personalized medicine	7
Monogenic forms of common variable immunodeficiency and implications on target therapeutic approaches	7
The complexity in DNA methylation analysis of allergic diseases	7
Precision allergy molecular diagnosis applications in food allergy	6
Immunobiologicals and ocular surface disease	6
The role of macrolides in chronic rhinosinusitis and nasal polyps	6
Interstitial lung diseases in inborn errors of immunity	6
Adverse effects of anti-cancer biologics on the ocular surface	6
Current strategies for phenotyping and managing asthma in preschool children	6
Anaphylaxis and Coronavirus Disease 2019 vaccine: a danger relationship?	6
Precision medicine to personalize medicine in allergic airway disease	6

Access from healthcare professionals to evidence-based pharmacotherapy in allergy management	6
Neurotrophic keratitis: inflammatory pathogenesis and novel therapies	6
Pathology of T-cell-mediated drug hypersensitivity reactions and impact of tolerance mechanisms on patient susceptibility	6
Do bacterial vaccines/adjuvants prevent wheezing episodes in children?	6
Exposome mapping in chronic respiratory diseases: the added value of digital technology	6
Atopic dermatitis and ocular allergy: common mechanisms and uncommon questions	6
Occupational respiratory allergy to reactive dyes	6
Poor statistical reporting: do we have a reason for concern? A narrative review and recommendations	6
Predictive models and applicability of artificial intelligence-based approaches in drug allergy	5
New insights in mite immunotherapy – sublingual tablets	5
Giant cell arteritis and innovative treatments	5
Editorial introductions	5
Editorial introductions	5
Assessment of receptor affinities of ophthalmic and systemic agents in dry eye disease	5
Type-2-low severe asthma endotypes for new treatments: the new asthma frontier	5
Real-life studies in allergen immunotherapy	5
Mechanisms underlying host defense and disease pathology in response to severe acute respiratory syndrome (SARS)-CoV2 infection: insights from inborn errors of immunity	5
Omalizumab is the Columbus egg for food allergies	5
New causes of occupational allergic contact dermatitis	5
Comparison of structural components and functional mechanisms within the skin vs. the conjunctival surface	5
The development of the DEFASE project	4
New insights into the diagnosis and management of Stevens–Johnson syndrome and toxic epidermal necrolysis	4
The risk of anaphylaxis on holidays	4
Moderate asthma: burden, mechanisms and therapeutic perspectives	4
Neurostimulation for dry eye disease	4
New insights into the mechanisms of aspirin-exacerbated respiratory disease	4
Diagnostic criteria of chronic conjunctivitis: atopic keratoconjunctivitis and vernal keratoconjunctivitis	4
How E-cigarettes and vaping can affect asthma in children and adolescents	4
Role of type-2 innate lymphoid cells (ILC2s) in type-2 asthma	4
MicroCrystalline Tyrosine-adsorbed immunotherapy	4
New evidence in food allergies treatment	4
Ocular surface disorders: office procedures for the allergist/clinical immunologist	4
Anaphylaxis and digital medicine	4
Editorial introductions	4
Update on aspirin exacerbated respiratory disease with chronic rhinosinusitis	4
Editorial: Pharmacotherapy and evidence based medicine	4
Clinical outcomes of AIT in the elderly population	4
Transgenic murine models for the study of drug hypersensitivity reactions linked to HLA-I molecules	4
Endotypes of occupational asthma	4
Role of biologics in severe food allergy	4
An update on patient reported outcomes in type 2 inflammation airway disease	4
Editorial introductions	4
Atopic endotypes as a modulating factor for SARS-CoV-2 infection: mechanisms and implications	4
Highlights of the treatment of allergic rhinitis according to Chinese guidelines	4
Integrative therapeutics for ocular surface disorders	3
Advances in gene therapy for inborn errors of immunity	3
Editorial introductions	3
Diagnosis, management and therapeutic options for eosinophilic esophagitis	3
Editorial introductions	3
Predicting the course of asthma from childhood until early adulthood	3
Biologics to treat anaphylaxis	3
Anaphylaxis viewed by experts: unmet needs	3
Classifying cephalosporins: from generation to cross-reactivity	3
Corneal complications of rheumatoid arthritis	3
Global patterns of drug allergy-induced fatalities: a wake-up call to prevent avoidable deaths	3
Editorial introductions	3
Anaphylaxis in elderly people	3
Resolving the genetics of human tryptases: implications for health, disease, and clinical use as a biomarker	3
Editorial introductions	3
Applying the new guidelines to asthma management in children	3
Management of food allergy based on oral food challenge	3
Biologics and severe asthma in children	3
Recent advances in the diagnosis and management of tree nut and seed allergy	3
Perioperative anaphylaxis: updates on pathophysiology	3
Genetic landscape of atopic dermatitis	3
STAT1 and STAT3 gain of function: clinically heterogenous immune regulatory disorders	3
The evolution of cyclosporine treatments for treatment of ocular surface diseases	3